Publication | Closed Access
Atazanavir is not associated with an increased risk of cardio or cerebrovascular disease events
107
Citations
9
References
2013
Year
These results argue against a class-wide association between exposure to HIV protease inhibitors and the risk of cardio/cerebrovascular events.
| Year | Citations | |
|---|---|---|
Page 1
Page 1